Posted On: 02/22/2012 12:13:32 AM
Post# of 1279

Teva Premium Swells on $250 Million Settlement: Israel Overnight
Teva Pharmaceutical Industries Ltd. climbed in New York, pushing the premium over Israeli stock to a six-week high, on speculation the drugmaker is settling lawsuits alleging a treatment led patients to develop hepatitis C.

